A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

Vaccines train the body's defenses to fight infections safely. Learn how vaccines work, how the immune system responds, and ...

Lung and skin cancer patients who were taking "checkpoint inhibitors" and had the COVID vaccine saw surprising results.

The team used the AMG1541 LNP to deliver an mRNA influenza vaccine in mice. They compared this vaccine’s effectiveness to a flu vaccine made with the lipid SM-102, which is FDA-approved and was used ...

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

COVID-19 mRNA vaccines significantly increased survival times in patients with advanced lung and skin cancer undergoing ...

By now, you know that the COVID-19 vaccine is the best way to protect against severe COVID infections and reduce your chances ...

A new lipid nanoparticle could make mRNA vaccines more powerful and potentially lower the cost per vaccine dose.

All of these questions deserve urgent exploration. Unfortunately, the discovery comes at a particularly difficult moment for ...

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

A stunning new study offers early evidence that COVID-19 vaccines might have a secret superpower: A precisely timed mRNA shot could help many cancer patients live longer.